Stifel Financial’s Epizyme, Inc EPZM Stock Holding History

Stifel Financial’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$15K	–	3436
2022 Q2	$15K	Hold	10,000	–	–	﹤0.01%	3288
2022 Q1	$12K	Buy	+10,000	New	+$16.3K	﹤0.01%	3356

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Stifel Financial's EPZM Position: Q3 2022 in Review

Stifel Financial sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 10,000 shares — an estimated $15K sold.

Stifel Financial first reported a position in EPZM in Q1 2022 and held it in 2 quarters. The position peaked at $15K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Stifel Financial reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Stifel Financial sold 10,000 Epizyme, Inc shares in Q3 2022, an estimated $15K.
Stifel Financial first reported a position in Epizyme, Inc in Q1 2022 and held it in 2 quarters.
Stifel Financial's Epizyme, Inc position peaked at $15K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Stifel Financial's 13F filing for Q3 2022, filed 14 Nov 2022.